People with B-PLL typically have a less favorable outlook. However, new targeted treatments in development may improve outcomes. This cancer affects immature cells in the immune system called ...

B-cell depletion with unconjugated CD20 monoclonal antibody (mAb) is used to treat rheumatoid arthritis and other autoimmune diseases. CD20-targeted immunotherapy depletes mature B cells through ...